Delivery Order SPE2DB22D1202-SPE2DB25FUTQ1
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4566698091 KETOROLAC 15 MG/ML vials. The firm-fixed-price contract has a ceiling value of $4,639.86 and an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,607.40. The order is for the supply of KETOROLAC 30 MG/ML VIALML, a medication, to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of 4,554,701,804 ketorolac 10 mg tablets. The firm-fixed-price delivery order, valued at $2,106.93, has a completion date of September 9, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,529,542 units of Ketorolac 15 mg/ml vial. The $1,072.43 delivery order contract has a firm fixed price pricing type and a completion date of May 8, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,351.13 firm fixed-price delivery order is for the supply of ketorolac 30 mg/ml vial, a pain management medication. The contract, which does not have a set-aside designation, has an ultimate completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 30 mg/ml vials. The contract has a total ceiling value of $1,344.56 and a completion date of February 3, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,020.12 award is for the supply of 4,565,063 units of the pain medication Ketorolac 10 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,016.51 Firm Fixed Price Delivery Order covers the supply of 4566583230 KETOROLAC 30 MG/ML VIALML, a specialized medication. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,939.60, is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of KETOROLAC 30 MG/ML VIAL. The $2,624.72 firm-fixed-price contract has a period of performance through May 29, 2024 and is not set aside. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025, which serves as the...